[go: up one dir, main page]

WO2008111020A3 - Macrolide derivatives as antibacterial agents - Google Patents

Macrolide derivatives as antibacterial agents Download PDF

Info

Publication number
WO2008111020A3
WO2008111020A3 PCT/IB2008/050979 IB2008050979W WO2008111020A3 WO 2008111020 A3 WO2008111020 A3 WO 2008111020A3 IB 2008050979 W IB2008050979 W IB 2008050979W WO 2008111020 A3 WO2008111020 A3 WO 2008111020A3
Authority
WO
WIPO (PCT)
Prior art keywords
compounds disclosed
antibacterial agents
spp
macrolide derivatives
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2008/050979
Other languages
French (fr)
Other versions
WO2008111020A2 (en
Inventor
Anjan Chakrabarti
Yogesh Baban Surase
Jitendra Sambhaji Jadhav
Biswajit Das
Dilip Upadhyay
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of WO2008111020A2 publication Critical patent/WO2008111020A2/en
Publication of WO2008111020A3 publication Critical patent/WO2008111020A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

The present invention provides macrolide derivatives, which can be used as antibacterial agents. Compounds disclosed herein can be used for treating or preventing conditions caused by or contributed to by gram positive, gram negative or anaerobic bacteria, more particularly against, for example, Staphylococci, Streptococci, Enterococci, Haemophilus, Moraxalla spp., Chlamydia spp., Mycoplasm, Legionella spp., Mycobacterium, Helicobacter, Clostridium, Bacteroides, Corynebacterium, Bacillus, Enterobactericeae or any combination thereof. Also provided, are the processes for preparing the compounds disclosed herein, pharmaceutical compositions containing compounds disclosed herein, and methods of treating bacterial infections.
PCT/IB2008/050979 2007-03-14 2008-03-14 Macrolide derivatives as antibacterial agents Ceased WO2008111020A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN551/DEL/2007 2007-03-14
IN551DE2007 2007-03-14

Publications (2)

Publication Number Publication Date
WO2008111020A2 WO2008111020A2 (en) 2008-09-18
WO2008111020A3 true WO2008111020A3 (en) 2008-11-13

Family

ID=39730790

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2008/050979 Ceased WO2008111020A2 (en) 2007-03-14 2008-03-14 Macrolide derivatives as antibacterial agents

Country Status (1)

Country Link
WO (1) WO2008111020A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104610402A (en) * 2014-12-30 2015-05-13 晋江市托美汀生物科技有限公司 Preparation method of macrolide impurity

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104558069B (en) * 2014-12-31 2017-01-04 广东东阳光药业有限公司 The synthetic method of macrolide impurity
CN108727445B (en) * 2018-06-29 2021-06-11 宜昌东阳光生化制药有限公司 Synthesis method of azithromycin impurity F

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999016779A1 (en) * 1997-09-30 1999-04-08 Abbott Laboratories 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
WO2000012521A1 (en) * 1998-08-26 2000-03-09 Abbott Laboratories 3', 3'-n-bis-desmethyl-3'-n-cycloalkyl erythromycin derivatives as lhrh antagonists
WO2007129646A1 (en) * 2006-05-01 2007-11-15 Taisho Pharmaceutical Co., Ltd. Macrolide derivative

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999016779A1 (en) * 1997-09-30 1999-04-08 Abbott Laboratories 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity
WO2000012521A1 (en) * 1998-08-26 2000-03-09 Abbott Laboratories 3', 3'-n-bis-desmethyl-3'-n-cycloalkyl erythromycin derivatives as lhrh antagonists
WO2007129646A1 (en) * 2006-05-01 2007-11-15 Taisho Pharmaceutical Co., Ltd. Macrolide derivative

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"The Merck Index", 2001, MERCK & CO., WHITEHOUSE STATION, NJ, XP002495203 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104610402A (en) * 2014-12-30 2015-05-13 晋江市托美汀生物科技有限公司 Preparation method of macrolide impurity
CN104610402B (en) * 2014-12-30 2017-01-25 晋江市托美汀生物科技有限公司 Preparation method of macrolide impurity

Also Published As

Publication number Publication date
WO2008111020A2 (en) 2008-09-18

Similar Documents

Publication Publication Date Title
BRPI0513903A (en) ketolide derivatives useful as antimicrobial agents, their preparation processes and pharmaceutical compositions comprising the same
MX348083B (en) Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof.
WO2007136719A3 (en) Biotherapeutic compositions comprising probiotic escherichia coli and uses thereof
WO2010013222A8 (en) Pyrrole carboxylic acid derivatives as antibacterial agents
NZ591051A (en) C7-fluoro substituted tetracycline compounds
MY162692A (en) Boron-containing small molecules
WO2007116322A3 (en) Purification of bacterial antigens
WO2006117762A3 (en) Antimicrobial agents
WO2011019839A3 (en) Glycopeptide and lipoglycopeptide antibiotics with improved solubility
WO2009085277A3 (en) Use of anti-connexin 43 polynucleotides for the treatment of abnormal or excessive scars
MX2010004407A (en) CARBACEPHEM beta-LACTAM ANTIBIOTICS.
TW200734344A (en) Antibacterial agents
WO2007060518A3 (en) Ketolide derivatives as antibacterial agents
WO2009073545A3 (en) Tetrahydro-isoquinoline ppat inhibitors as antibacterial agents
WO2007089612A3 (en) Methods and compositions for treating and preventing bacterial infections
WO2009042270A3 (en) Reca inhibitors and their uses as microbial inhibitors or potentiators of antibiotic activity
WO2006046112A3 (en) Ketolide derivatives as antibacterial agents
WO2008111020A3 (en) Macrolide derivatives as antibacterial agents
NZ584159A (en) 6,11-bridged biaryl macrolides
MXPA05009688A (en) Naphthyridine derivatives as antibacterial agents.
WO2006120563A3 (en) Antibacterial agents
MX2012001065A (en) Media for the specific detection of gram-negative bacteria resistant to beta-lactam antibiotics.
WO2007060618A3 (en) Macrolides derivatives as antibacterial agents
WO2012073214A3 (en) Heptose derivatives for use in the treatment of bacterial infections
WO2008110918A3 (en) Erythromycin-based macrolides

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08719715

Country of ref document: EP

Kind code of ref document: A2